| Old Articles: <Older 30511-30520 Newer> |
|---|
 |
The Motley Fool
June 4, 2008
Brian Lawler |
Erbitux's Deceptively Disappointing Results Poorly received lead-drug data batters ImClone shares.   |
The Motley Fool
June 4, 2008
Kristin Graham |
Asia's Sinful Profit Opportunity Macau is building its gambling empire bigger and faster than what seems imaginable. |
The Motley Fool
June 4, 2008
Rich Duprey |
Foolish Forecast: Ahead of the Curve With Quiksilver In advance of earnings, analysts expect surf and skate clothing retailer Quicksilver to post a small profit, as compared to last year's loss. |
The Motley Fool
June 4, 2008
Rick Aristotle Munarriz |
Yahoo! Casts a Wider Net Yahoo! announces several new deals, including two with Wal-Mart and CBS, all geared toward broadening the company's advertising reach. |
The Motley Fool
June 4, 2008
Toby Shute |
No Recession at the Scrap Yard Despite a slowing economy, salvage vehicle auctioneer Copart turns in a terrific quarter. |
The Motley Fool
June 4, 2008
Christopher Barker |
The Gas Fire That Scorched the World A gas disruption challenges mining operations in Western Australia. |
The Motley Fool
June 4, 2008
Mac Greer |
Fool Video: What's the Next "Iron Man" for Investors? "Iron Man," "Hulk," "Wall-e," and the stocks behind these new movies are discussed in this video. |
The Motley Fool
June 4, 2008
Rich Smith |
Lions Gate Is the Cat's Meow Lions Gate may be more profitable than investors realize, and it may be on sale now. |
The Motley Fool
June 4, 2008
Rich Duprey |
Two Smokin' Barrels at Gander Mountain The sporting-goods chain posts a wider loss even though consumers arm themselves to the teeth. |
The Motley Fool
June 4, 2008
Brian Orelli |
Expanding Possibilities Fail to Expand Rigel's Stock Price Rigel gets positive data on a second indication for its lead drug, R788. |
| <Older 30511-30520 Newer> Return to current articles. |
